Inclination Towards Technological Upswing To Bolster The Needless Blood Drawing System Market

The standard way of drawing blood by venipuncture has been replaced by a new device, needless blood drawing system, which is a pain-free alternative. The needless blood drawing system draws sufficient amount of blood for a wide range of tests, within the same time duration taken by a standard procedure.

With this device, the risks of injuries in patients suffering from chronic diseases, who have to perform periodic blood tests, have been reduced. The standard way of drawing blood by venipuncture creates uneasiness to the patient. The needless blood drawing system collects the blood without any pain and is a user-friendly process, which has reduced the risk of infection.

Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/22882

Segmentations-

By End-user

• Hospitals
• Diagnostics Laboratories
• Ambulatory Surgical Centers

Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

The global market for needless blood drawing system is expected to be driven by the advancements in technology. Incidence of venous access difficulties due to obesity, age, and other diseases have increased the need of needless blood system. Blood tests are the basic tests a doctor asks for before diagnosing a particular disease.

For the entire list of market players, request for Table of Content here @ https://www.persistencemarketresearch.com/toc/22882

The virtually painless needless blood drawing systems are expected to replace over 400 Mn traditional blood drawing systems in the U.S. Ease of use and low risks of infections with painless procedure of blood drawing market system are responsible for growing penetration of these devices across all the end-users.

Due to these reasons, the hospitals around the world are shifting towards needless blood drawing devices to minimize the risk of needlestick injuries in repeated blood draws as well as the labor cost. Besides, end users and manufacturers of needless blood drawing systems are collaborating for better product development.

North America is expected to remain the dominant market in the global needless blood drawing system market due to the increasing number of hospital admissions for chronic diseases.

According to the Hospital of the University of Pennsylvania, almost every inpatient admitted in the hospital’s care typically receives at least 1 daily blood collection, and 25% of hospital admissions receive 3 or more collections per day.

Pre-Book Right Now for Exclusive Analyst Support @ https://www.persistencemarketresearch.com/checkout/22882

Over the course of the admission, approximately 3% of patients receive more than 100 blood collections during their stay. Emerging markets such as the Asia Pacific and Latin America are expected to experience delayed growth due to the late introduction of these devices in the market.

The global market for needless blood drawing systems is highly consolidated. Examples of some of the key players identified in the global needless blood drawing system market are Velano Vascular, Tasso Inc., Seventh Sense Biosystems. Also, a lot of companies such as Siemens AG, Ionis Pharmaceuticals, Novartis International AG are investing in needless blood drawing systems.